{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:57:34Z","timestamp":1776329854133,"version":"3.50.1"},"reference-count":13,"publisher":"Baskent University","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.6002\/ect.2023.0111","type":"journal-issue","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T03:24:17Z","timestamp":1741922657000},"source":"Crossref","is-referenced-by-count":1,"title":[],"prefix":"10.6002","volume":"23","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Lurje I, Czigany Z, Bednarsch J, et al. Treatment strategies for hepatocellular carcinoma \u207b a multidisciplinary approach. Int J Mol Sci. 2019;20(6):1465. doi:10.3390\/ijms20061465","DOI":"10.3390\/ijms20061465"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693-699. doi:10.1056\/NEJM199603143341104","DOI":"10.1056\/NEJM199603143341104"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30(6):1434-1440. doi:10.1002\/hep.510300629","DOI":"10.1002\/hep.510300629"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. de'Angelis N, Landi F, Carra MC, Azoulay D. Managements of recurrent hepatocellular carcinoma after liver transplantation: a systematic review. World J Gastroenterol. 2015;21(39):11185-11198. doi:10.3748\/wjg.v21.i39.11185","DOI":"10.3748\/wjg.v21.i39.11185"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Kim M, Rhu J, Choi GS, Kim JM, Joh JW. Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation. Ann Surg Treat Res. 2021;101(1):28-36. doi:10.4174\/astr.2021.101.1.28","DOI":"10.4174\/astr.2021.101.1.28"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol. 2012;13(1):e11-22.","DOI":"10.1016\/S1470-2045(11)70175-9"},{"key":"ref6","unstructured":"7. Lai Q, Avolio AW, Manzia TM, Sorge R, Agnes S, Tisone G. Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation. Clin Transplant. 2014;28(4):428-36."},{"issue":"7","key":"ref7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/ctr.12755","article-title":"Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation","volume":"30","author":"Andreou","year":"2016","unstructured":"8. Andreou A, Bahra M, Schmelzle M, et al. Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation. Clin Transplant. 2016;30(7):819-827.","journal-title":"Clin Transplant"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Rana A, Hardy MA, Halazun KJ, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant. 2008;8(12):2537-2546. doi:10.1111\/j.1600-6143.2008.02400.x","DOI":"10.1111\/j.1600-6143.2008.02400.x"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Agopian VG, Harlander-Locke M, Zarrinpar A, et al. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. J Am Coll Surg. 2015;220(4):416-427. doi:10.1016\/j.jamcollsurg.2014.12.025","DOI":"10.1016\/j.jamcollsurg.2014.12.025"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Lee S, Kwon CH, Kim JM, et al. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation. Liver Transpl. 2014;20(9):1057-1063. doi:10.1002\/lt.23919","DOI":"10.1002\/lt.23919"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Au KP, Chok KS. Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: a proposed management algorithm. World J Gastroenterol. 2018;24(45):5081-5094. doi:10.3748\/wjg.v24.i45.5081","DOI":"10.3748\/wjg.v24.i45.5081"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Pelizzaro F, Gambato M, Gringeri E, et al. Management of hepatocellular carcinoma recurrence after liver transplantation. Cancers (Basel). 2021;13(19):4882. doi:10.3390\/cancers13194882","DOI":"10.3390\/cancers13194882"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T03:36:30Z","timestamp":1741923390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/archive\/2025\/23\/2\/0\/133\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2023.0111","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}